ADORA2A and neoplasm: The percentage of A2AR-expressing macrophages among CD3+/CD45+ cells was lower in the TME than in the spleen, and macrophage A2AR expression in the tumor was significantly higher after combined therapy with cordycepin and anti-PD1 than after anti-PD1 treatment alone.